NCT06887699 The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System
| NCT ID | NCT06887699 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Defense Medical Center, Taiwan |
| Condition | OMI - Occlusion Myocardial Infarction |
| Study Type | INTERVENTIONAL |
| Enrollment | 212,000 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2028-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 212,000 participants in total. It began in 2025-08-01 with a primary completion date of 2028-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.
Eligibility Criteria
Inclusion Criteria: * Patients in the emergency department * Patients received at least 1 ECG examination. Exclusion Criteria: * The patients received ECG at the period of inactive AI-ECG system. * Patients with a history of coronary angiography within the past 3 days.
Contact & Investigator
Chin Lin, PhD
PRINCIPAL INVESTIGATOR
National Defense Medical Center
Frequently Asked Questions
Who can join the NCT06887699 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying OMI - Occlusion Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06887699 currently recruiting?
Yes, NCT06887699 is actively recruiting participants. Contact the research team at xup6fup@mail.ndmctsgh.edu.tw for enrollment information.
Where is the NCT06887699 trial being conducted?
This trial is being conducted at Kaohsiung City, Taiwan, Taipei, Taiwan, Taipei, Taiwan.
Who is sponsoring the NCT06887699 clinical trial?
NCT06887699 is sponsored by National Defense Medical Center, Taiwan. The principal investigator is Chin Lin, PhD at National Defense Medical Center. The trial plans to enroll 212,000 participants.